Check Capital Management’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
Check Capital Management's DGX Position: Q3 2026 in Review
Check Capital Management sold out of Quest Diagnostics (DGX) in Q3 2026, closing a stake of 1,300 shares — an estimated $276K sold.
Check Capital Management first reported a position in DGX in Q3 2020 and held it in 24 quarters. The position peaked at $30.8M in Q4 2021. 1,126 funds tracked by Wall St. Rank hold DGX as of Q3 2026.
- Check Capital Management reported no remaining Quest Diagnostics position as of Q3 2026 after selling out during the quarter.
- Check Capital Management sold 1,300 Quest Diagnostics shares in Q3 2026, an estimated $276K.
- Check Capital Management first reported a position in Quest Diagnostics in Q3 2020 and held it in 24 quarters.
- Check Capital Management's Quest Diagnostics position peaked at $30.8M in Q4 2021.
- 1,126 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2026.
Based on Check Capital Management's 13F filing for Q3 2026, filed 5 Nov 2026.